Ginkgo Bioworks Investors
Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.
Funding Status:
IPO
Industry:
Biopharma, Biotechnology, Chemical
Estimated Revenue:
$50M to $100M
Number Of Exists:
1
Headquarters:
Boston, Massachusetts, United States
Total Funding:
1573728100
Last Funding Type:
Post-IPO Equity
Employee Number:
501-1000
Founded Date:
2008-01-01